Abvc Biopharma Stock Technical Analysis
| ABVC Stock | USD 2.02 0.06 2.88% |
As of the 1st of February, ABVC Biopharma shows the Market Risk Adjusted Performance of (2.89), variance of 14.86, and Mean Deviation of 3.02. ABVC Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.
ABVC Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ABVC, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ABVCABVC Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Will Biotechnology sector continue expanding? Could ABVC diversify its offerings? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ABVC Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding ABVC Biopharma requires distinguishing between market price and book value, where the latter reflects ABVC's accounting equity. The concept of intrinsic value—what ABVC Biopharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push ABVC Biopharma's price substantially above or below its fundamental value.
Understanding that ABVC Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ABVC Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, ABVC Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
ABVC Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ABVC Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ABVC Biopharma.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in ABVC Biopharma on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding ABVC Biopharma or generate 0.0% return on investment in ABVC Biopharma over 90 days. ABVC Biopharma is related to or competes with Reviva Pharmaceuticals, Grace Therapeutics, PDS Biotechnology, Actinium Pharmaceuticals, Jupiter Neurosciences, Tvardi Therapeutics, and Lantern Pharma. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet me... More
ABVC Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ABVC Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ABVC Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 16.32 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 6.44 |
ABVC Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABVC Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ABVC Biopharma's standard deviation. In reality, there are many statistical measures that can use ABVC Biopharma historical prices to predict the future ABVC Biopharma's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | (2.90) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ABVC Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ABVC Biopharma February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (2.89) | |||
| Mean Deviation | 3.02 | |||
| Coefficient Of Variation | (713.16) | |||
| Standard Deviation | 3.85 | |||
| Variance | 14.86 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | (2.90) | |||
| Maximum Drawdown | 16.32 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 6.44 | |||
| Skewness | (0.15) | |||
| Kurtosis | 0.3803 |
ABVC Biopharma Backtested Returns
ABVC Biopharma secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of volatility over the last 3 months. ABVC Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ABVC Biopharma's Market Risk Adjusted Performance of (2.89), variance of 14.86, and Mean Deviation of 3.02 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ABVC Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABVC Biopharma is expected to be smaller as well. At this point, ABVC Biopharma has a negative expected return of -0.54%. Please make sure to confirm ABVC Biopharma's accumulation distribution, and the relationship between the potential upside and day median price , to decide if ABVC Biopharma performance from the past will be repeated in the future.
Auto-correlation | 0.66 |
Good predictability
ABVC Biopharma has good predictability. Overlapping area represents the amount of predictability between ABVC Biopharma time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ABVC Biopharma price movement. The serial correlation of 0.66 indicates that around 66.0% of current ABVC Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ABVC Biopharma Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ABVC Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About ABVC Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ABVC Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ABVC Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ABVC Biopharma price pattern first instead of the macroeconomic environment surrounding ABVC Biopharma. By analyzing ABVC Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ABVC Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ABVC Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
ABVC Biopharma February 1, 2026 Technical Indicators
Most technical analysis of ABVC help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ABVC from various momentum indicators to cycle indicators. When you analyze ABVC charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (2.89) | |||
| Mean Deviation | 3.02 | |||
| Coefficient Of Variation | (713.16) | |||
| Standard Deviation | 3.85 | |||
| Variance | 14.86 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | (2.90) | |||
| Maximum Drawdown | 16.32 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 6.44 | |||
| Skewness | (0.15) | |||
| Kurtosis | 0.3803 |
ABVC Biopharma February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ABVC stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.75) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 2.06 | ||
| Day Typical Price | 2.05 | ||
| Price Action Indicator | (0.07) | ||
| Market Facilitation Index | 0.08 |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |